Latest filing published 05 Apr 2021 for Vir Biotechnology, Inc., €5,855.
Filing timeline
BuySaleInsider track record
Jay Parrish: trading record in brief
This profile gathers the share dealings of Jay Parrish in Vir Biotechnology, Inc. Between 14 May 2020 and 1 April 2021, the trades on record add up to 32 filings.
No open-market purchase appears, only 12 sales worth €9.5M. Other entries cover 20 option exercises. So far in 2021, the count stands at no purchases and 4 sales.
The newest entry dates from 5 April 2021: an option exercise of €5,855, in Vir Biotechnology, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jay Parrish
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,629 shares@ US$1.490.1% of flowCommon StockSEC:0001209191-21-025194:0
- 2,315 shares@ US$1.580.0% of flowCommon StockSEC:0001209191-21-025194:1
- 6,944 shares@ US$51.403.1% of flowCommon StockSEC:0001209191-21-025194:2
- 4,630 shares@ US$1.490.1% of flowCommon StockSEC:0001209191-21-016880:0
- 2,314 shares@ US$1.580.0% of flowCommon StockSEC:0001209191-21-016880:1
- 6,944 shares@ US$63.443.7% of flowCommon StockSEC:0001209191-21-016880:2
- 4,630 shares@ US$1.580.1% of flowCommon StockSEC:0001209191-21-006880:1
- 6,944 shares@ US$69.914.1% of flowCommon StockSEC:0001209191-21-006880:2
- 2,314 shares@ US$1.490.0% of flowCommon StockSEC:0001209191-21-006880:0
- 6,945 shares@ US$1.490.1% of flowCommon StockSEC:0001209191-21-001158:0
- 6,945 shares@ US$26.321.5% of flowCommon StockSEC:0001209191-21-001158:1
- 4,630 shares@ US$1.4850.1% of flowCommon StockSEC:0001209191-20-061253:0
- 2,315 shares@ US$1.5750.0% of flowCommon StockSEC:0001209191-20-061253:1
- 6,945 shares@ US$31.52882.1% of flowCommon StockSEC:0001209191-20-061253:2
- 4,629 shares@ US$1.4850.1% of flowCommon StockSEC:0001209191-20-056681:0
- 2,315 shares@ US$1.5750.0% of flowCommon StockSEC:0001209191-20-056681:1
- 6,944 shares@ US$31.2722.2% of flowCommon StockSEC:0001209191-20-056681:2
- 4,630 shares@ US$1.4850.1% of flowCommon StockSEC:0001209191-20-053260:0
- 2,315 shares@ US$1.5750.0% of flowCommon StockSEC:0001209191-20-053260:1
- 6,945 shares@ US$34.75042.4% of flowCommon StockSEC:0001209191-20-053260:2
- 6,943 shares@ US$1.580.1% of flowCommon StockSEC:0001209191-20-049394:0
- 6,943 shares@ US$39.152.7% of flowCommon StockSEC:0001209191-20-049394:1
- 9,259 shares@ US$1.490.1% of flowCommon StockSEC:0001209191-20-044748:0
- 1,851 shares@ US$1.580.0% of flowCommon StockSEC:0001209191-20-044748:1
- 11,110 shares@ US$47.655.2% of flowCommon StockSEC:0001209191-20-044748:2
25 of 32 declarations
